Blazer, D.G. 3rd, Sabel, M.S. and Sondak, V.K. (2003) Is There a Role for Sentinel Lymph Node Biopsy in the Management of Sarcoma? Surgical Oncology, 12, 201-206.
https://doi.org/10.1016/S0960-7404(03)00030-6

has been cited by the following article:

• TITLE: Analysis of Sentinel Lymph Node Biopsy on Clear Cell Sarcoma Treatment

  AUTHORS: Eurico Cleto Ribeiro de Campos, Marcos Gonçalves Adriano Júnior, Marcus Rivabem Winheski, Ricardo Poroski, Diego Sanches, Robson Menezes Leal, Marcela Cavalcanti, Emanuela Benevides Poyer, Renan Martins

  KEYWORDS: Clear Cell Sarcomas, Soft Tissue Sarcoma, Sentinel Biopsy

  JOURNAL NAME: Journal of Cancer Therapy, Vol.11 No.12, December 15, 2020

  ABSTRACT: Clear Cell Sarcoma (CCS) is a rare soft tissue sarcoma that corresponds to a less than 1% of all sarcomas and is a high degree neoplasm with propensity to disseminate to regional lymph nodes. Regional lymphadenectomies have a controversial impact on sarcomas treatment and survival, even though those patients have higher local recurrence and lower survival. So, sentinel lymph node biopsy must be one option for better regional staging to STS with higher propensity to lymph node commitment. The authors demonstrate two cases of CCS submitted to surgery through compartmental resection associated with the sentinel lymph node biopsy. A literature review about soft tissue sarcoma and lymph node sentinel biopsy is shown as an initial experience of two cases.